BWM
ORGO icon

Baystate Wealth Management’s Organogenesis Holdings ORGO Stock Holding History

Baystate Wealth Management’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,500
Closed -$6K – 715
2020
Q2 		$6K Buy
+1,500
New +$5.41K ﹤0.01% 444

Other funds holding ORGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Baystate Wealth Management's ORGO Position: Q3 2020 in Review

Baystate Wealth Management sold out of Organogenesis Holdings (ORGO) in Q3 2020, closing a stake of 1,500 shares — an estimated $6K sold.

Baystate Wealth Management first reported a position in ORGO in Q2 2020 and held it in 1 quarter. The position peaked at $6K in Q2 2020. 50 funds tracked by Wall St. Rank hold ORGO as of Q3 2020.

  • Baystate Wealth Management reported no remaining Organogenesis Holdings position as of Q3 2020 after selling out during the quarter.
  • Baystate Wealth Management sold 1,500 Organogenesis Holdings shares in Q3 2020, an estimated $6K.
  • Baystate Wealth Management first reported a position in Organogenesis Holdings in Q2 2020 and held it in 1 quarter.
  • Baystate Wealth Management's Organogenesis Holdings position peaked at $6K in Q2 2020.
  • 50 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q3 2020.

Based on Baystate Wealth Management's 13F filing for Q3 2020, filed 14 Oct 2020.